Comparison of two doses of intravitreal bevacizumab (avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American collaborative retina study group at 6 months of follow-up

PURPOSE: To report the 6-month anatomical and visual outcomes after injecting two different doses of intravitreal bevacizumab in patients with macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: An interventional, retrospective multicenter study of 45 eyes that were treated wit...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2008

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22934

Acceso en línea:

https://doi.org/10.1097/IAE.0b013e3181619bee
https://repository.urosario.edu.co/handle/10336/22934

Palabra clave:

Bevacizumab
Triamcinolone
Angiogenesis inhibitor
Bevacizumab
Monoclonal antibody
Vasculotropin a
Adult
Aged
Article
Branch retinal artery occlusion
Ciliary disk
Clinical article
Clinical trial
Controlled study
Drug dose comparison
Female
Human
Laser coagulation
Male
Multicenter study
Retina macula edema
Retina neovascularization
Treatment outcome
Visual acuity
Vitrectomy
Comparative study
Drug antagonism
Fluorescence angiography
Follow up
Injection
Middle aged
Optical coherence tomography
Retina macula edema
Retina vein occlusion
Retrospective study
Vitreous body
Aged
Angiogenesis inhibitors
Female
Fluorescein angiography
Follow-up studies
Humans
Injections
Macular edema
Male
Middle aged
Retinal vein occlusion
Retrospective studies
Treatment outcome
Vascular endothelial growth factor a
Visual acuity
Vitreous body
Bevacizumab
Branch retinal vein occlusion
Macular edema
Vascular endothelial growth factor
optical coherence
monoclonal
Antibodies
Tomography

Rights

License

Abierto (Texto Completo)